Compare Novartis AG (NVS) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Veritone Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: Novartis AG is far larger — about 2973.9× Veritone Inc's market cap, and Novartis AG pays a 3.17% dividend while Veritone Inc pays none. Which is the better fit depends on your goals.
| NVS | VERI | |
|---|---|---|
Market Cap | $290.25B | $97.60M |
Sector | Health | Technology |
52-Week High | $168.62 | $8.39 |
52-Week Low | $113.50 | $1.02 |
Enterprise Value | $330.27B | $129.63M |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
